According to Fact.MR, a source of market research and competitive information, the global dental membrane and bone graft alternatives market is expected to grow at a CAGR of over 8% from 2021 to 2031. One of the main factors influencing demand for dental membranes and bone graft alternatives is the rising frequency of oral health conditions including cavities and gum disorders.
Unhealthy diets, cigarette use, excessive alcohol use, and poor dental hygiene are some of the causes of oral health problems. Dental membrane and bone graft replacements are frequently utilized in periodontal defect regeneration, sinus lift operations, socket preservation, implant bone regeneration, ridge augmentation, and other dental treatments.
Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=6475
Key Market Segments in Dental Membrane and Bone Graft Substitutes Industry Research
Type
- Resorbable Dental Membrane and Bone Graft Substitutes
- Non-resorbable Dental Membrane and Bone Graft Substitutes
- Autograft Dental Membrane and Bone Graft Substitutes
- Allograft Dental Membrane and Bone Graft Substitutes
- Xenograft Dental Membrane and Bone Graft Substitutes
- Synthetic Dental Membrane and Bone Graft Substitutes
Material
- Hydrogel Dental Membrane and Bone Graft Substitutes
- Collagen Dental Membrane and Bone Graft Substitutes
- Human Cells Source Dental Membrane and Bone Graft Substitutes
- Hydroxyapatite Dental Membrane and Bone Graft Substitutes
- Tricalcium Phosphate Dental Membrane and Bone Graft Substitutes
Key Takeaways from Market Study
- Global dental membrane and bone graft substitutes market to top US$ 900 Mn by 2031.
- Resorbable dental membranes are projected to reach around US$ 400 Mn by 2031.
- Market in Japan to record 4% CAGR over the forecast period of 2021- 2031.
- China forecast to reach a projected market size of above US$ 200 Mn by 2031.
- Market in Canada projected to expand at above 5% CAGR over the next 10 years.
Market Competition
Product launches and product approvals are commonly adopted by companies to expand their footprints and product portfolios worldwide, and meet the growing demand. Players operating in the market are adopting the strategy of expansion to enlarge their customer base, which permits them to maintain their brand name globally.
- In 2017, LifeNet Health launched PliaFX Strip allograft for dental and bone healing. The product provides high efficiency.
- In 2018, Geistlich Pharma North America Inc. launched alternative soft tissue graft, Geistlich Fibro-Gide, in its portfolio of collagen matrices.
- In May 2018, Dentsply Sirona, entered into a distribution collaboration agreement with Datum Dental, Ltd for the distribution of the Ossix product line, enabling the firm to expand its customer base in North America.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
